Toggle Main Menu Toggle Search

Open Access padlockePrints

Genome-Wide Association Study of Genetic Predictors of Anti-Tumor Necrosis Factor Treatment Efficacy in Rheumatoid Arthritis Identifies Associations With Polymorphisms at Seven Loci

Lookup NU author(s): Dr Kate Potter, Professor John IsaacsORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Objective. Anti-tumor necrosis factor (anti-TNF) agents are successful therapies in rheumatoid arthritis (RA); however, inadequate response occurs in 30-40% of patients treated. Knowledge of the genetic factors that influence response may facilitate personalized therapy. The purpose of this study was to identify genetic predictors of response to anti-TNF therapy in RA and to validate our findings in independent cohorts. Methods. Data from genome-wide association (GWA) studies were available from the Wellcome Trust Case Control Consortium for 566 anti-TNF-treated RA patients. Multivariate linear regression analysis of changes in the Disease Activity Score in 28 joints at 6 months was conducted at each single-nucleotide polymorphism (SNP) using an additive model. Associated markers (P < 10(-3)) were genotyped in 2 independent replication cohorts (n = 379 and n = 341), and a combined analysis was performed. Results. Of 171 successfully genotyped markers demonstrating association with treatment response in the GWA data, 7 were corroborated in the combined analysis. The strongest effect was at rs17301249, mapping to the EYA4 gene on chromosome 6: the minor allele conferred improved response to treatment (coefficient -0.27, P = 5.67(-05)). The minor allele of rs1532269, mapping to the PDZD2 gene, was associated with a reduced treatment response (coefficient 0.20, P = 7.37(-04)). The remaining associated SNPs mapped to intergenic regions on chromosomes 1, 4, 11, and 12. Conclusion. Using a genome-wide strategy, we have identified and validated the association of 7 genetic loci with response to anti-TNF treatment in RA. Additional confirmation of these findings in further cohorts will be required.

Publication metadata

Author(s): Plant D, Bowes J, Potter C, Hyrich KL, Morgan AW, Wilson AG, Isaacs JD, Barton A, British Soc Rheumatology Biol

Publication type: Article

Publication status: Published

Journal: Arthritis & Rheumatism

Year: 2011

Volume: 63

Issue: 3

Pages: 645-653

Print publication date: 25/02/2011

ISSN (print): 0004-3591

ISSN (electronic): 1529-0131

Publisher: John Wiley & Sons, Inc.


DOI: 10.1002/art.30130


Altmetrics provided by Altmetric


Funder referenceFunder name
NIHR Manchester Biomedical Research Centre
17552Arthritis Research UK